Sorainen has advised Estonia-based health technology start-up Nanordica Medical on raising EUR 375,000.
According to Sorainen, the funding round was led by Estonian health and startup investors, including Founding Partner of Health Founders and Managing Partner of Verge HeathTech Fund Erki Molder, European Innovation Council IC Member Heidi Kakko, and Head of Tallinn Science Park Tehnopol Martin Gorosko, with the participation of angel investors from Estonia, Germany, Finland, Belgium, and Switzerland.
According to the firm, "Nanordica Medical is developing advanced antibacterial wound care products to avoid infection-related amputations. Nanordica Medical has invented and patented nanotechnology that provides eight times better treatment of infected wounds compared to the standard of care."
Nanordica Medical is a spin-off from "the National Institute of Chemical Physics and Biophysics, a member of the UK P4SY Precision Medicine Accelerator, and an alumnus of the Estonian Tehnopol Startup Incubator and Health Founders Accelerator," Sorainen reported. "The money raised in the current round will be used to conduct clinical trials to test the antibacterial wound care product and to accelerate the certification necessary for the commercialization of the product."
Sorainen’s team included Partner Toomas Prangli, Senior Associate Mirell Prosa, and Associates Vladislav Leiri and Kevin Piho.
Sorainen did not respond to our inquiry on the matter.
